Vitamin K: The Complete Guide to How It Works, Where It Comes From, and Why It Matters
Vitamin K sits in a curious position among nutrients: essential for life, present in many common foods, and yet consistently misunderstood — or overlooked entirely — until something goes wrong. It doesn't get the cultural attention of vitamin D or vitamin C, but its roles in the body are precise and consequential. Understanding what vitamin K actually is, how its different forms function, and what shapes how the body uses it requires going a level deeper than most general nutrition overviews do.
What Vitamin K Actually Is — and Why "K" Isn't One Thing
Vitamin K is a fat-soluble vitamin, meaning it dissolves in fat rather than water and requires dietary fat for absorption. But calling it a single vitamin is a simplification. Vitamin K exists in several distinct chemical forms, and those forms behave differently in the body.
The two forms that matter most in human nutrition are vitamin K1 (phylloquinone) and vitamin K2 (menaquinones). K1 is the form found predominantly in plant foods, especially leafy green vegetables. K2 is a family of related compounds — called MK-4 through MK-13, depending on the length of their molecular side chain — found in fermented foods, animal products, and produced in small amounts by bacteria in the gut.
A third form, vitamin K3 (menadione), is a synthetic compound not used in standard dietary supplements due to safety concerns at high doses; it appears primarily in research contexts and some animal feed formulations.
The distinction between K1 and K2 matters because they differ in how efficiently the body absorbs them, how long they circulate, and which tissues they reach. K1 is absorbed and cleared relatively quickly. The longer-chain K2 forms — particularly MK-7, found in the fermented soybean food natto — remain in circulation longer and appear to reach tissues beyond the liver more effectively, including bone and the walls of blood vessels. Whether that translates into meaningfully different health outcomes for most people is an active area of research, not yet settled science.
The Core Functions: What Vitamin K Does in the Body 🩸
Vitamin K's best-established role is as a cofactor for carboxylation — a chemical process that activates certain proteins by enabling them to bind calcium. Without adequate vitamin K, these proteins remain inactive. This affects two primary systems:
Blood coagulation (clotting): Several clotting factors — proteins produced by the liver that allow blood to clot properly after injury — depend on vitamin K to function. This is vitamin K's most established physiological role and the basis for one of its most significant drug interactions (discussed below). Both excessive bleeding and impaired wound healing can signal disruptions in this system.
Calcium metabolism in bone and cardiovascular tissue: A group of vitamin K-dependent proteins, including osteocalcin (involved in bone mineralization) and Matrix Gla Protein (MGP) (which helps prevent calcium from depositing in arteries and soft tissues), require vitamin K to become active. Research suggests these proteins play a role in how the body directs calcium — toward bone where it belongs and away from blood vessel walls where it can cause harm. The evidence here is promising but more complex than headlines often suggest; observational studies have found associations between higher vitamin K intake and markers of bone and cardiovascular health, but clinical trials demonstrating cause-and-effect outcomes are ongoing and not yet conclusive.
Food Sources: Where Vitamin K Comes From in the Diet
The most concentrated dietary sources of K1 are dark leafy greens — kale, spinach, Swiss chard, collard greens, broccoli, and Brussels sprouts are among the highest. Vegetable oils, particularly soybean and canola oil, also contribute meaningful amounts.
K2 sources are narrower and less familiar to most Western diets. Natto (fermented soybeans) contains exceptionally high concentrations of MK-7 — significantly more than any other food. Hard and soft cheeses, egg yolks, chicken liver, butter, and other full-fat animal products provide lower but notable amounts of various MK forms, particularly MK-4. Fermented foods like certain yogurts and sauerkraut contain smaller quantities.
| Food | Primary K Form | Notes |
|---|---|---|
| Kale, spinach, collard greens | K1 (phylloquinone) | Among the highest K1 sources per serving |
| Broccoli, Brussels sprouts | K1 | Moderate to high K1 content |
| Natto (fermented soybeans) | K2 as MK-7 | Exceptionally high; far above other foods |
| Hard cheeses (e.g., Gouda, Edam) | K2 as MK-4, MK-9 | Higher K2 than soft cheeses |
| Egg yolk, chicken liver | K2 as MK-4 | Animal-sourced; modest amounts |
| Soybean oil, canola oil | K1 | Contributes to daily intake in typical diets |
Because vitamin K is fat-soluble, consuming K1-rich vegetables alongside a source of dietary fat meaningfully improves absorption. Eating raw spinach with no fat produces lower absorption than eating it with olive oil or another fat source — a practical detail that matters more than it might seem.
Deficiency: Who Is at Risk and What It Looks Like
Outright vitamin K deficiency is uncommon in healthy adults eating a varied diet, but it does occur in specific contexts. The most widely recognized risk groups include:
Newborns, who have limited vitamin K stores at birth and immature gut flora that help produce K2. This is why vitamin K prophylaxis (typically an injection) at birth is standard practice in most countries — to prevent vitamin K deficiency bleeding (VKDB), a rare but serious condition.
People with fat malabsorption conditions — including Crohn's disease, celiac disease, cystic fibrosis, and short bowel syndrome — may absorb significantly less vitamin K regardless of dietary intake, because fat-soluble vitamin absorption depends on functional fat digestion.
People on long-term antibiotic therapy may have reduced gut bacterial production of K2, though dietary sources remain available.
Those with very low dietary fat intake may absorb K1 less efficiently even when eating K-rich vegetables.
In adults, early or subclinical vitamin K inadequacy may not produce obvious symptoms but can affect the activation of vitamin K-dependent proteins — a status not well captured by standard clinical tests. Research into reliable biomarkers for vitamin K status, such as undercarboxylated osteocalcin and undercarboxylated MGP, is ongoing.
The Variables That Shape How Vitamin K Works for Different People 🔬
Several factors significantly influence how much vitamin K a person absorbs, retains, and uses — which is why intake data alone tells an incomplete story.
Dietary fat intake affects absorption directly. Gut health and microbiome composition influence K2 production and absorption. Age matters because intestinal absorption efficiency generally changes over time, and older adults may face different baseline risks for bone and cardiovascular issues where vitamin K-dependent proteins are implicated. Genetic variants affecting vitamin K metabolism — including variants in the VKORC1 gene — are well-documented and explain some of the significant individual variation in how people respond to both dietary vitamin K and medications that interact with it.
Medications are among the most clinically significant variables. Warfarin (Coumadin) and related anticoagulant drugs work precisely by blocking vitamin K's role in clotting factor production. Anyone taking these medications faces a real and well-documented need to keep their vitamin K intake consistent — not necessarily low, but stable — because fluctuations can directly affect how the medication works. This is one of the more consequential nutrient-drug interactions in clinical nutrition. Other fat-soluble vitamins — particularly vitamin A and vitamin E at high supplemental doses — may also interact with vitamin K absorption and metabolism.
Supplement form introduces its own variables. K1 supplements are widely available and inexpensive. K2 supplements come in MK-4 and MK-7 forms, which differ in dose, duration of action, and cost. MK-7 requires much lower doses to achieve circulating levels comparable to higher-dose MK-4 preparations, based on its longer half-life — but both forms are used in research, often at different dosages, making direct comparisons complicated.
Intake Guidelines: What Reference Values Look Like
Vitamin K intake guidelines are typically expressed as an Adequate Intake (AI) rather than a Recommended Dietary Allowance (RDA) — the distinction reflects that the evidence base hasn't yet allowed for a full RDA calculation the way it has for some other nutrients. In the U.S., the AI for adults is generally 90–120 micrograms (mcg) per day, varying by sex, with higher values during pregnancy and lactation in some frameworks. Guidelines differ somewhat between countries.
It's worth noting that established intake guidelines are based primarily on K1's role in blood clotting, not necessarily on optimizing K2-dependent processes like bone mineralization or vascular calcification prevention — a gap that researchers have pointed out and that remains under active discussion.
There is no established Tolerable Upper Intake Level (UL) for vitamin K1 or K2 from food or standard supplements in most regulatory frameworks, as toxicity from natural forms has not been demonstrated in the research literature. This is distinct from the synthetic K3 form, which has shown toxicity at high doses.
Key Questions Readers Explore Within This Topic
Vitamin K1 vs. K2 is the question that anchors much of the nuanced discussion in this space — not just what the difference is, but whether it matters for specific health outcomes, and whether typical diets supply enough of each form. The evidence picture is clearer for K1's clotting role than for K2's effects on bone density and arterial calcification, where research is active but human trial data remains limited.
Vitamin K and bone health draws considerable interest, particularly as populations age and osteoporosis risk increases. The role of osteocalcin activation and whether supplemental K2 meaningfully affects bone mineral density or fracture risk is a subject of ongoing clinical research with mixed findings across different study designs and populations.
Vitamin K and cardiovascular health centers on MGP — a protein that, when insufficiently activated due to low K2 status, may allow calcium to deposit in arterial walls. Observational research in this area is interesting, but translating it into firm dietary guidance requires a level of evidence that trials are still working to establish.
Vitamin K and warfarin interaction is a topic with direct clinical significance for a large number of people. Understanding how to maintain consistent vitamin K intake — and what that actually means in practice — is a practical and important area distinct from the general nutrition questions.
Vitamin K for newborns and infants is its own focused area, given that K deficiency bleeding is a neonatal concern with a well-established preventive protocol, and parents often have questions about how this relates to dietary intake during infancy and breastfeeding.
Vitamin K in supplements — including what forms are available, how they compare, what research says about supplemental versus dietary sources, and what factors influence whether supplementing makes sense — rounds out the practical questions most readers eventually reach.
What those questions ultimately converge on is the same gap that runs through all of vitamin K research: the science explains how the mechanisms work with considerable precision, but how those mechanisms translate into outcomes for any specific person depends on health status, diet, medications, age, and genetic factors that no general overview can assess. The landscape here is clearer than it was a decade ago — and still has meaningful territory left to map.
